{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-18T12:25:32.904695+00:00",
  "news": [
    {
      "title": "2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOcWprWDR1WDBZZHhaOHM3NVBFRXlsd3d2UTRQQjU2cnlmS2hkVEFSb1lJX3A1dUlvbnZrRVZ1N0lXTXJsWGVNeWRXZ0d1T0t0Z0F0d2g3RzlWOXRnM1Ffa3FhVTloLW5yNmMzcGNCWURtN3ZBVU1lT0RING5tc3cxX284Z2JBVk14VlREWDJlRDF4MS1weHBtU2tzYlRvZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOcWprWDR1WDBZZHhaOHM3NVBFRXlsd3d2UTRQQjU2cnlmS2hkVEFSb1lJX3A1dUlvbnZrRVZ1N0lXTXJsWGVNeWRXZ0d1T0t0Z0F0d2g3RzlWOXRnM1Ffa3FhVTloLW5yNmMzcGNCWURtN3ZBVU1lT0RING5tc3cxX284Z2JBVk14VlREWDJlRDF4MS1weHBtU2tzYlRvZw?oc=5\" target=\"_blank\">2025 at Amgen: Investing, Expanding, and Serving More Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-18T00:52:02+00:00",
      "source": "Amgen"
    },
    {
      "title": "Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQVTUxMHRtUFN6SXZNN216blRXRkNOVmlkdHdobzJmemVTaTY4X2dCekFKOW52VjNrT2szX00wbHZKajEyR3BpbG1NUzlUSlJ3UzJxNE1neHJYSk15aXRWMUFPZ2VaUmMzOEU3S3l5T1NOVUx1R2o5MEhFVTVhYUY2c3FDM0hKUDB0cXJUcFZ1XzlkMTcwTUVkT3gxSUwzTEM5TjRHNHdDUXBkeTVzYVZ0dnNHaXlQdXhOeTk2d01zX3VYbmdKNzNfa1BB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxQVTUxMHRtUFN6SXZNN216blRXRkNOVmlkdHdobzJmemVTaTY4X2dCekFKOW52VjNrT2szX00wbHZKajEyR3BpbG1NUzlUSlJ3UzJxNE1neHJYSk15aXRWMUFPZ2VaUmMzOEU3S3l5T1NOVUx1R2o5MEhFVTVhYUY2c3FDM0hKUDB0cXJUcFZ1XzlkMTcwTUVkT3gxSUwzTEM5TjRHNHdDUXBkeTVzYVZ0dnNHaXlQdXhOeTk2d01zX3VYbmdKNzNfa1BB?oc=5\" target=\"_blank\">Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-18T09:57:35+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNcFgtLU1MR3FVR3BCdlpfX3V6Y3ViTTNxYmhBczJQVHhJRnFka1JXVWs1aFpHcmswWTZ0OWp3ZU92T1ZIQTVkS0pFMXlSaFBnbS1yVTJSelptRGYzRjNHTjF0cVRnMC1idlg1SVM1Uzk0OEd1azNDNUkwNThDSWRNMzluTGNib0k?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNcFgtLU1MR3FVR3BCdlpfX3V6Y3ViTTNxYmhBczJQVHhJRnFka1JXVWs1aFpHcmswWTZ0OWp3ZU92T1ZIQTVkS0pFMXlSaFBnbS1yVTJSelptRGYzRjNHTjF0cVRnMC1idlg1SVM1Uzk0OEd1azNDNUkwNThDSWRNMzluTGNib0k?oc=5\" target=\"_blank\">Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-17T14:00:03+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdzdabm5oVWZTbklRTE1GUEdQWFNOTnFQOFdUZF9rU2FwZ1ZaRzJoZDdCS1hYdy1ZQUdUNXhSaUNfYmFjV2RjR3MzaTlRNkZSNU1wOHBYcXhkSmw4VUcxRDgzMktpcjk4YktMWmZUNzFCQXRMazJHMThUX2JMUGVOUnAyMWhJQlNQX19OUURxQ3A0dmVZc2dnN201WHJucnFndTdfZ0pB?oc=5\" target=\"_blank\">Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-12T14:49:19+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "HSBC Turns More Bullish on Amgen (AMGN) into 2026 - Insider Monkey",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPTmgtZjVkRHA4azJKNnlSeU81ZG5WNlRhWlBHb0RGMTN0bGN5OC1xMnFLWlVGQVEwTkFYeU85X1pRY3Vnb1BhQzdxLVJYUHFEYUMtSy03cWJ1MGktTmx4dl9xRDNEa19SeTBvdVM3cldxekEwUlNWckNIUndLV2hQV3NLRXlSOVB3dkx0NTlUd1NTV3BfSnfSAZ4BQVVfeXFMUHVJWWlfNjZTaVRyLWYycnl2QXBkU2dub1UtRExadGZmVmI2TWNKenpOczlnOEVHLUJqX25uT2wxVk5IaHFMRHI2dTZoX3MyekwtNFAzRE1mWjRER0RzdkdsMHdvaXZnNXJUdDF1VDRNSEVkbTFpQ0Z3bmRQMDhhRlpwNEZuLVp6Q0pGUUxhTXFjdXVpVTZzVW1VOWZzY3c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxPTmgtZjVkRHA4azJKNnlSeU81ZG5WNlRhWlBHb0RGMTN0bGN5OC1xMnFLWlVGQVEwTkFYeU85X1pRY3Vnb1BhQzdxLVJYUHFEYUMtSy03cWJ1MGktTmx4dl9xRDNEa19SeTBvdVM3cldxekEwUlNWckNIUndLV2hQV3NLRXlSOVB3dkx0NTlUd1NTV3BfSnfSAZ4BQVVfeXFMUHVJWWlfNjZTaVRyLWYycnl2QXBkU2dub1UtRExadGZmVmI2TWNKenpOczlnOEVHLUJqX25uT2wxVk5IaHFMRHI2dTZoX3MyekwtNFAzRE1mWjRER0RzdkdsMHdvaXZnNXJUdDF1VDRNSEVkbTFpQ0Z3bmRQMDhhRlpwNEZuLVp6Q0pGUUxhTXFjdXVpVTZzVW1VOWZzY3c?oc=5\" target=\"_blank\">HSBC Turns More Bullish on Amgen (AMGN) into 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
      "published": "2025-12-17T19:22:16+00:00",
      "source": "Insider Monkey"
    },
    {
      "title": "Amgen (AMGN) Among Pharma Giants in Drug Pricing Talks - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNZU4xNTVRQi1jT2FmdjJ4bTVKRkJBQUZON2NlbElzaEpWc2twZHZsWXFCR0IzTEdaSUlLWHpZTXFqTWJlUzEzQVBXU3ZaRDBzTXpUMUg0djZwNHRmTURIbWs1LTRTSU5EY1prcV9wTUpWZ2JWR0FZTkt5UlRSOEt3bFJwNDBCMUg4YWJXX1BvckhnVzc1VWc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxNZU4xNTVRQi1jT2FmdjJ4bTVKRkJBQUZON2NlbElzaEpWc2twZHZsWXFCR0IzTEdaSUlLWHpZTXFqTWJlUzEzQVBXU3ZaRDBzTXpUMUg0djZwNHRmTURIbWs1LTRTSU5EY1prcV9wTUpWZ2JWR0FZTkt5UlRSOEt3bFJwNDBCMUg4YWJXX1BvckhnVzc1VWc?oc=5\" target=\"_blank\">Amgen (AMGN) Among Pharma Giants in Drug Pricing Talks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2025-12-17T19:04:19+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Amgen Sees RS Rating Improve To 71 - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOUWhrZ3huMDMyd1ZISHVWa1o1TXpTR2lRTlpfbXhSd3k0Ny1VTHgxNXIxYTd0WjhaeGs4dENfb1hkLWZjdTV6UnlXR2FIY1JINzNBTHRBVmk3bndNX1FEZFFlRDRPQzgwMkVidXBJMGVRWmJPQUxEY1dUbnFKUGpmQVpadEk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxOUWhrZ3huMDMyd1ZISHVWa1o1TXpTR2lRTlpfbXhSd3k0Ny1VTHgxNXIxYTd0WjhaeGs4dENfb1hkLWZjdTV6UnlXR2FIY1JINzNBTHRBVmk3bndNX1FEZFFlRDRPQzgwMkVidXBJMGVRWmJPQUxEY1dUbnFKUGpmQVpadEk?oc=5\" target=\"_blank\">Amgen Sees RS Rating Improve To 71</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-12-15T08:00:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "FDA Action Alert: BMS, GSK, Amgen and More - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9aS2o5UFZsVUxEN1FiY2pnSFBYMjhZUVVXSlNhTjBWYkVGbkRHZEVic0hkbTNVeDFvcWdwVjJDYXpTU2lLc25nMWI1cXNFUVlSM2liRjllQ0JSWHI0RV93UGJmNGZtTkdmc3EySnhZR1FGVTY1RkFN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTE9aS2o5UFZsVUxEN1FiY2pnSFBYMjhZUVVXSlNhTjBWYkVGbkRHZEVic0hkbTNVeDFvcWdwVjJDYXpTU2lLc25nMWI1cXNFUVlSM2liRjllQ0JSWHI0RV93UGJmNGZtTkdmc3EySnhZR1FGVTY1RkFN?oc=5\" target=\"_blank\">FDA Action Alert: BMS, GSK, Amgen and More</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-12-01T08:00:00+00:00",
      "source": "BioSpace"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-17",
      "close": 326.010009765625
    },
    "history": [
      {
        "date": "2025-12-09",
        "close": 313.8500061035156
      },
      {
        "date": "2025-12-10",
        "close": 315.3800048828125
      },
      {
        "date": "2025-12-11",
        "close": 317.3800048828125
      },
      {
        "date": "2025-12-12",
        "close": 317.739990234375
      },
      {
        "date": "2025-12-15",
        "close": 325.30999755859375
      },
      {
        "date": "2025-12-16",
        "close": 326.739990234375
      },
      {
        "date": "2025-12-17",
        "close": 326.010009765625
      }
    ],
    "name": "Amgen Inc."
  }
}